BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 3817172)

  • 1. Urinary human chorionic gonadotropin among intrauterine device users: detection with a highly specific and sensitive assay.
    Wilcox AJ; Weinberg CR; Armstrong EG; Canfield RE
    Fertil Steril; 1987 Feb; 47(2):265-9. PubMed ID: 3817172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Absence of chorionic gonadotropin in sera of women who use intrauterine devices.
    Segal SJ; Alvarez-Sanchez F; Adejuwon CA; Brache de Mejia V; Leon P; Faundes A
    Fertil Steril; 1985 Aug; 44(2):214-8. PubMed ID: 4018277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The secretion of human chorionic gonadotropin-like substance in women employing contraceptive measures.
    Huang SC; Chen HC; Chen RJ; Hsieh CY; Wei PY; Ouyang PC
    J Clin Endocrinol Metab; 1984 Apr; 58(4):646-53. PubMed ID: 6699130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pregnancy-specific beta 1-glycoprotein and chorionic gonadotropin-like immunoreactivity during the latter half of the cycle in women using intrauterine contraception.
    Seppälä M; Rutanen EM; Jalanko H; Lehtovirta P; Stenman UH; Engvall E
    J Clin Endocrinol Metab; 1978 Dec; 47(6):1216-9. PubMed ID: 318094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early chorionic activity in women bearing inert IUD, copper IUD and levonorgestrel-releasing IUD.
    Videla-Rivero L; Etchepareborda JJ; Kesseru E
    Contraception; 1987 Aug; 36(2):217-26. PubMed ID: 3123135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of human chorionic gonadotropin in blood of regularly bleeding women using copper intrauterine contraceptive devices.
    Landesman R; Coutinho EM; Saxena BB
    Fertil Steril; 1976 Sep; 27(9):1062-6. PubMed ID: 964399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human chorionic gonadotropin in intrauterine device users.
    Shalit A; Jaschevatzky OE; Kampf D; Leiserowitz DM; Grünstein S
    Int J Fertil; 1980; 25(2):134-6. PubMed ID: 6117529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Norplant implants: the mechanism of contraceptive action.
    Segal SJ; Alvarez-Sanchez F; Brache V; Faundes A; Vilja P; Tuohimaa P
    Fertil Steril; 1991 Aug; 56(2):273-7. PubMed ID: 1906407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The mode of action of IUDs.
    Ortiz ME; Croxatto HB
    Contraception; 1987 Jul; 36(1):37-53. PubMed ID: 3311625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absence of circulating chorionic gonadotropin in wearers of intrauterine contraceptive devices.
    Klein TA; Mishell DR
    Am J Obstet Gynecol; 1977 Nov; 129(6):626-8. PubMed ID: 920763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Demonstration of human chorionic gonadotropin during the second half of the menstrual cycle in plasma of regularly menstruating women users of copper IUds.
    Capitanio GL; Conte N; Ragni N; Rossato P; Pedretti E
    Acta Eur Fertil; 1978 Mar; 9(1):11-9. PubMed ID: 696185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Levels of HCG in subjects using the Progestasert(TM) intrauterine progesterone systems.
    Custo GM; Carenza L; Pala A
    Contraception; 1980 Mar; 21(3):311-7. PubMed ID: 6771092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early pregnancy factor as a monitor for fertilization in women wearing intrauterine devices.
    Smart YC; Fraser IS; Clancy RL; Roberts TK; Cripps AW
    Fertil Steril; 1982 Feb; 37(2):201-4. PubMed ID: 6174375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transitory hCG-like activity in the urine of some IUD users.
    Hodgen GD; Chen HC; Dufau ML; Klein TA; Mishell DR
    J Clin Endocrinol Metab; 1978 Apr; 46(4):698-701. PubMed ID: 755054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Presence of elevated circulating levels of LH during the pre-menstrual period in some copper IUD users and the possibility of their confusion with hCG.
    Dattatreyamurty B; Joshi J; Mehta S; Virkar KD; Sheth AR
    Contraception; 1979 Mar; 19(3):213-21. PubMed ID: 455978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum levels of pregnancy-specific beta 1-glycoprotein (SP1) and human chorionic gonadotropin (beta-hCG) in women using an intrauterine device.
    Tamsen L; Eneroth P
    Contraception; 1986 May; 33(5):497-501. PubMed ID: 2428559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Appearance of hCG in pregnancy plasma following the initiation of implantation of the blastocyst.
    Catt KJ; Dufau ML; Vaitukaitis JL
    J Clin Endocrinol Metab; 1975 Mar; 40(3):537-40. PubMed ID: 1117063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of beta subunit HCG in plasma of IUD users as an indication of frequency of conception.
    Nilsson CG; Lähteenmäki P; Luukkainen T
    Int J Fertil; 1979; 24(2):134-7. PubMed ID: 40908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intrauterine devices. The optimal long-term contraceptive method?
    Fortney JA; Feldblum PJ; Raymond EG
    J Reprod Med; 1999 Mar; 44(3):269-74. PubMed ID: 10202746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence of early loss of pregnancy.
    Wilcox AJ; Weinberg CR; O'Connor JF; Baird DD; Schlatterer JP; Canfield RE; Armstrong EG; Nisula BC
    N Engl J Med; 1988 Jul; 319(4):189-94. PubMed ID: 3393170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.